Fate names Grayson CEO, Mendlein executive chairman

Adult stem cell company Fate Therapeutics (Seattle, Wash.) hired Paul Grayson as president and CEO and John Mendlein as executive chairman. Previously, Grayson was managing director at Sanderling Vent...